On the Histone Lysine Methyltransferase Activity of Fungal Metabolite Chaetocin

Journal of Medicinal Chemistry
2013.0

Abstract

Histone lysine methyltransferases (HKMTs) are an important class of targets for epigenetic therapy. 1 (chaetocin), an epidithiodiketopiperazine (ETP) natural product, has been reported to be a specific inhibitor of the SU(VAR)3-9 class of HKMTs. We have studied the inhibition of the HKMT G9a by 1 and functionally related analogues. Our results reveal that only the structurally unique ETP core is required for inhibition, and such inhibition is time-dependent and irreversible (in the absence of DTT), ultimately resulting in protein denaturation. Mass spectrometric data provide a molecular basis for this effect, demonstrating covalent adduct formation between 1 and the protein. This provides a potential rationale for the selectivity observed in the inhibition of a variety of HKMTs by 1 in vitro and has implications for the activity of ETPs against these important epigenetic targets.

Knowledge Graph

Similar Paper

On the Histone Lysine Methyltransferase Activity of Fungal Metabolite Chaetocin
Journal of Medicinal Chemistry 2013.0
Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9
Nature Chemical Biology 2005.0
Epidithiodiketopiperazine as a pharmacophore for protein lysine methyltransferase G9a inhibitors: Reducing cytotoxicity by structural simplification
Bioorganic & Medicinal Chemistry Letters 2013.0
Inhibition of histone lysine methyltransferases G9a and GLP by ejection of structural Zn(II)
Bioorganic & Medicinal Chemistry Letters 2018.0
Recent progress in histone methyltransferase (G9a) inhibitors as anticancer agents
European Journal of Medicinal Chemistry 2019.0
Histone lysine methyltransferase structure activity relationships that allow for segregation of G9a inhibition and anti-Plasmodium activity
MedChemComm 2017.0
Identification of protoberberine alkaloids as novel histone methyltransferase G9a inhibitors by structure-based virtual screening
Journal of Computer-Aided Molecular Design 2018.0
Discovery of Novel Substrate-Competitive Lysine Methyltransferase G9a Inhibitors as Anticancer Agents
Journal of Medicinal Chemistry 2023.0
Analogues of the Natural Product Sinefungin as Inhibitors of EHMT1 and EHMT2
ACS Medicinal Chemistry Letters 2014.0
Discovery of a Novel Chemotype of Histone Lysine Methyltransferase EHMT1/2 (GLP/G9a) Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Co-crystal Structure
Journal of Medicinal Chemistry 2019.0